Emerging studies suggest this peptide, a dual activator targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , could offer a notable advancement for weight loss . Initial human investigations have indicated substantial reductions in body fat , potentially exceeding existing weight-loss therapies . However , further … Read More